Dow Up0.08% Nasdaq Down0.30%

Heartware International Inc. (HTWR)

-NasdaqGS
81.53 Down 1.72(2.07%) Sep 19, 4:15PM EDT
|After Hours : 81.53 0.00 (0.00%) Sep 19, 4:40PM EDT
ProfileGet Profile for:
Heartware International Inc.
500 Old Connecticut Path
Framingham, MA 01701
United States - Map
Phone: 508-739-0950
Website: http://www.heartware.com.au

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:569

Business Summary 

HeartWare International, Inc., a medical device company, is engaged in developing and manufacturing miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States and internationally. The company offers HeartWare Ventricular Assist System, which includes a VAD, or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. It is also developing the MVAD, a miniaturized blood pump, intended for chronic heart failure patients; and the SYNERGY Circulatory Support System, a partial support system designed to treat less sick, ambulatory, chronic heart failure patients who are not yet inotrope-dependent. In addition, HeartWare International, Inc. collaborates with Dualis MedTech GmbH for the development of an implantable system. The company markets its products directly to cardiac centers and hospitals, as well as through medical device distributors. HeartWare International, Inc. is headquartered in Framingham, Massachusetts.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Heartware International Inc.

Corporate Governance 
Heartware International Inc.’s ISS Governance QuickScore as of Sep 1, 2014 is 9. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 7; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Douglas E. Godshall M.B.A., 49
Chief Exec. Officer, Pres, Managing Director and Exec. Director
824.00K4.11M
Mr. Peter F. McAree , 49
Chief Financial Officer, Principal Accounting Officer, Sr. VP and Treasurer
441.00K0.00
Mr. Jeffrey A. LaRose MSME, 53
Chief Scientific Officer and Exec. VP
439.00K966.00K
Mr. Lawrence J. Knopf , 52
Sr. VP, Gen. Counsel and Sec.
442.00K0.00
Mr. James Schuermann BS, MBA, 46
Sr. VP of Sales and Marketing
410.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders